DE602004013021D1 - Herstellung eines alpha-1-proteinaseinhibitors im grossmassstab und dessen verwendung - Google Patents

Herstellung eines alpha-1-proteinaseinhibitors im grossmassstab und dessen verwendung

Info

Publication number
DE602004013021D1
DE602004013021D1 DE602004013021T DE602004013021T DE602004013021D1 DE 602004013021 D1 DE602004013021 D1 DE 602004013021D1 DE 602004013021 T DE602004013021 T DE 602004013021T DE 602004013021 T DE602004013021 T DE 602004013021T DE 602004013021 D1 DE602004013021 D1 DE 602004013021D1
Authority
DE
Germany
Prior art keywords
preparation
months
api
alpha
large scale
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004013021T
Other languages
English (en)
Other versions
DE602004013021T2 (de
DE602004013021T3 (de
Inventor
Shabtai Bauer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kamada Ltd
Original Assignee
Kamada Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34379546&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602004013021(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from IL15805303A external-priority patent/IL158053A0/xx
Application filed by Kamada Ltd filed Critical Kamada Ltd
Publication of DE602004013021D1 publication Critical patent/DE602004013021D1/de
Publication of DE602004013021T2 publication Critical patent/DE602004013021T2/de
Application granted granted Critical
Publication of DE602004013021T3 publication Critical patent/DE602004013021T3/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8125—Alpha-1-antitrypsin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DE602004013021T 2003-09-22 2004-09-22 Herstellung eines alpha-1-proteinaseinhibitors im grossmassstab und dessen verwendung Active DE602004013021T3 (de)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US50390203P 2003-09-22 2003-09-22
IL15805303A IL158053A0 (en) 2003-09-22 2003-09-22 Process for large scale purification of alpha-1 proteinase inhibitor
US503902P 2003-09-22
IL15805303 2003-09-22
EP04770552A EP1664123B2 (de) 2003-09-22 2004-09-22 Herstellung eines alpha-1-proteinaseinhibitors im grossmassstab und dessen verwendung
PCT/IL2004/000881 WO2005027821A2 (en) 2003-09-22 2004-09-22 Large scale preparation of alpha-1 proteinase inhibitor and use thereof

Publications (3)

Publication Number Publication Date
DE602004013021D1 true DE602004013021D1 (de) 2008-05-21
DE602004013021T2 DE602004013021T2 (de) 2009-06-25
DE602004013021T3 DE602004013021T3 (de) 2012-04-05

Family

ID=34379546

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004013021T Active DE602004013021T3 (de) 2003-09-22 2004-09-22 Herstellung eines alpha-1-proteinaseinhibitors im grossmassstab und dessen verwendung

Country Status (12)

Country Link
US (2) US7879800B2 (de)
EP (1) EP1664123B2 (de)
AT (1) ATE391730T1 (de)
CA (1) CA2538998C (de)
DE (1) DE602004013021T3 (de)
DK (1) DK1664123T4 (de)
ES (1) ES2305845T5 (de)
IL (1) IL174410A0 (de)
PL (1) PL1664123T5 (de)
PT (1) PT1664123E (de)
SI (1) SI1664123T2 (de)
WO (1) WO2005027821A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0524432D0 (en) * 2005-11-30 2006-01-11 Nhs Blood & Transplant Method
US7973005B2 (en) 2006-02-09 2011-07-05 Kamada Ltd. Alpha-1 antitrypsin for treating exacerbation episodes of pulmonary diseases
JP5600061B2 (ja) 2007-08-17 2014-10-01 ツェーエスエル ベーリンク ゲゼルシャフト ミット ベシュレンクテル ハフツング α−１−抗トリプシンおよびアポリポタンパク質Ａ−Ｉを精製する方法
CN102099369A (zh) * 2008-07-18 2011-06-15 泰勒克里斯生物治疗学公司 制备α-1蛋白酶抑制剂的方法
PL2496246T3 (pl) 2009-11-03 2018-09-28 Grifols Therapeutics Llc Kompozycja, sposób i zestaw dla inhibitora proteinazy alpha-1
NZ600271A (en) 2009-11-24 2013-09-27 Grifols Therapeutics Inc Lyophilization methods, compositions, and kits
WO2012166622A1 (en) 2011-05-27 2012-12-06 Baxter International Inc. Therapeutic proteins with increased half-life and methods of preparing same
AU2012337241B2 (en) 2011-12-30 2016-10-13 Grifols, S.A. Alpha1-proteinase inhibitor for delaying the onset or progression of pulmonary exacerbations
TWI629283B (zh) 2012-02-23 2018-07-11 巴克斯歐塔公司 來自血漿中的免疫球蛋白之ｉ-ｉｖ-１部分沉澱
US9353165B2 (en) 2012-07-25 2016-05-31 Grifols, S.A. Purification of cell culture derived alpha1 protease inhibitor
IL267520B2 (en) * 2016-12-22 2023-09-01 Kamada Ltd Dry powder composition of alpha-1 antitrypsin
CA3054267A1 (en) * 2017-02-21 2018-08-30 Kamada Ltd. Methods and uses of alpha 1-antitrypsin for early intervention in pulmonary diseases
CA3085696A1 (en) 2017-12-12 2019-06-20 Kamada Ltd Methods of inducing immune tolerance and reducing anti-drug antibody response
IL267923B2 (en) 2018-08-02 2023-06-01 Grifols Worldwide Operations Ltd The composition containing the most concentrated alpha-1 type protein inhibitor and a method for obtaining it
WO2020157752A1 (en) * 2019-01-29 2020-08-06 Kamada Ltd Pharmaceutical aerosol composition

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4379087A (en) 1982-06-17 1983-04-05 Cutter Laboratories, Inc. Method of preparing alpha-1-proteinase inhibitor
US4439358A (en) 1982-06-17 1984-03-27 Miles Laboratories, Inc. Method of preparing alpha-1-proteinase inhibitor
US4683294A (en) 1985-04-03 1987-07-28 Smith Kline Rit, S.A. Process for the extraction and purification of proteins from culture media producing them
US4697003A (en) 1985-11-01 1987-09-29 Miles Laboratories, Inc. Method of preparing alpha-1-proteinase inhibitor
US4656254A (en) 1985-12-02 1987-04-07 Miles Laboratories, Inc. Method of preparing alpha-1-proteinase inhibitor and antithrombin III
US4629567A (en) 1986-03-07 1986-12-16 Smithkline-Rit Alpha-1-antiprotease purification
US4749783A (en) 1986-07-11 1988-06-07 Miles Laboratories, Inc. Viral inactivation and purification of active proteins
US5093316A (en) 1986-12-24 1992-03-03 John Lezdey Treatment of inflammation
ATE178094T1 (de) 1990-05-01 1999-04-15 Chiron Corp Interleukin-i antagonist und seine verwendung
US5814225A (en) 1994-06-09 1998-09-29 Shanbrom Technologies Llc Iodinated gel filtration media for disinfecting protein solutions
US6284874B1 (en) 1994-06-17 2001-09-04 Alpha Therapeutic Corporation Process for separating α1-proteinase inhibitor from cohn fraction IV1 and IV4 paste
US5610285A (en) 1994-08-24 1997-03-11 Bayer Corporation Purification of α-1 proteinase inhibitor using novel chromatographic separation conditions
EP0871671A1 (de) 1995-09-07 1998-10-21 PPL Therapeutics (Scotland) Limited Reinigung von alpha-1 proteininhibitoren
US5780440A (en) 1996-06-17 1998-07-14 Protease Sciences Inc. Treatment of pulmonary disease with protease inhibitors
TW491855B (en) * 1996-08-07 2002-06-21 Csl Ltd Purification of immunoglobulins
AT407114B (de) 1997-06-10 2000-12-27 Immuno Ag Alpha 1-antitrypsin-präparation sowie verfahren zu deren herstellung
US6093804A (en) 1998-09-24 2000-07-25 American National Red Cross Method for purification of alpha-1 proteinase inhibitor
US6462180B1 (en) * 1999-11-24 2002-10-08 Bayer Corporation Method of preparing α-1 proteinase inhibitor
AU2001245240A1 (en) * 2000-12-14 2002-06-24 Talecris Biotherapeutics, Inc. Method of preparing alpha-1 proteinase inhibitor
CA2478925C (en) 2002-04-26 2016-06-07 Robert Lee Fahrner Non-affinity purification of proteins
US7777006B2 (en) 2002-12-31 2010-08-17 Csl Behring L.L.C. Method for purification of alpha-1-antitrypsin
PT1654284E (pt) 2003-08-12 2009-07-06 Octapharma Ag Processo para preparar uma solução de alfa-1-antitripsina
DK1765866T3 (en) 2004-06-07 2014-03-24 Therapure Biopharma Inc ISOLATION OF plasma or serum protein

Also Published As

Publication number Publication date
AU2004273696A1 (en) 2005-03-31
EP1664123B2 (de) 2011-11-30
SI1664123T1 (sl) 2008-10-31
DE602004013021T2 (de) 2009-06-25
EP1664123A2 (de) 2006-06-07
US20080139465A1 (en) 2008-06-12
PT1664123E (pt) 2008-07-16
US7879800B2 (en) 2011-02-01
US20110092444A1 (en) 2011-04-21
IL174410A0 (en) 2006-08-01
ES2305845T3 (es) 2008-11-01
DK1664123T4 (da) 2012-03-05
DK1664123T3 (da) 2008-07-28
PL1664123T5 (pl) 2012-04-30
WO2005027821A3 (en) 2005-08-04
SI1664123T2 (sl) 2012-03-30
ATE391730T1 (de) 2008-04-15
EP1664123B1 (de) 2008-04-09
WO2005027821A2 (en) 2005-03-31
ES2305845T5 (es) 2012-04-12
PL1664123T3 (pl) 2008-11-28
EP1664123A4 (de) 2006-11-02
CA2538998C (en) 2015-11-24
CA2538998A1 (en) 2005-03-31
DE602004013021T3 (de) 2012-04-05

Similar Documents

Publication Publication Date Title
IL174410A0 (en) Large scale preparation of alpha-1 proteinase inhibitor and use thereof
DE60233137D1 (de) Transporter mit beabstandeten arginin-teilchen
DE60236541D1 (de) Inhibitoren von 11-beta-hydroxysteroiddehydrogenase typ 1
BRPI0412761A (pt) inibidores de serino proteases, particularmente a protease ns3-ns4a do vhc
BRPI0414176A (pt) inibidores de serina proteases, em particular hcv ns3-ns4a protease
BRPI0516825A (pt) inibição da protease ns3-ns4a do vìrus da hepatite c (vhc)
HUP0300850A2 (hu) Gyűrűs béta-aminosav-származékok mint mátrix metalloproteázok és a TNF-alfa inhibitorok és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
EA200201271A1 (ru) Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1
TW200510391A (en) Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
HUP0004529A2 (hu) VLA-4 által mediált leukocita adhéziót gátló szulfonilezett dipeptid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint alkalmazásuk
ATE381537T1 (de) Formanilid-derivative als beta2-adrenorezeptor- agonisten
EA200300776A1 (ru) Производные фенэтаноламина для лечения респираторных заболеваний
NO20075042L (no) Farmasoytisk sammensetning innbefattende en omega-karboksyarylsubstituert difenylurea for behandling av cancer
ATE396174T1 (de) Hydroxyalkylaminderivate als beta-secretase- inhibitoren und deren verwendung zur behandlung der alzheimerschen krankheit oder ähnlicher krankheiten
DK0548096T3 (da) Amphifile fluorderivater med telomerisk struktur, deres fremstilling og biomedicinske anvendelser
BRPI0418074B8 (pt) derivado de amida, composição farmacêutica, inibidor da tirosina cinase bcr-abl e agentes terapêuticos
SE9904421D0 (sv) New compounds
BR0308765A (pt) Compostos (4,2-dissubstituìdo-tiazol-5-il)amina como inibidores de pde7
ATE494894T1 (de) Viruzide wirkungen von einer zubereitung enthaltend cetylpyridiniumchlorid und zitronensäure
HUP0402602A2 (hu) Eljárás echinokandin-származékok előállítására, ezek alkalmazása, ezeket tartalmazó gyógyszerkészítmények és intermedierek
EA200400707A1 (ru) Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1
SE0101978D0 (sv) New compounds
HUP0303512A2 (hu) Biuretánszármazékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
HUP0000934A1 (hu) 4-{2-[N-(3-Fenoxi-2-hidroxi)-propil-amino]-etil}-anilid-származékok és az ezeket tartalmazó gyógyászati készítmények
Costa et al. Interaction of hypoxia and carbon tetrachloride toxicity in hepatocyte monolayers

Legal Events

Date Code Title Description
8363 Opposition against the patent
R102 Epo decision maintaining patent in amended form now final

Ref document number: 1664123

Country of ref document: EP

R102 Epo decision maintaining patent in amended form now final

Ref document number: 1664123

Country of ref document: EP

Effective date: 20111130